Joana Nicolau Ramis, Lluís Masmiquel Comas. Show Affiliations »
Abstract
Entities: Species
Mesh： See more » AnimalsBreast Neoplasms/chemically inducedBreast Neoplasms/epidemiologyCalcitonin/metabolismCarcinoma, Medullary/chemically inducedClinical Trials as Topic/statistics & numerical dataComorbidityDiabetes Mellitus, Type 2/drug therapyDiabetes Mellitus, Type 2/epidemiologyDipeptidyl Peptidase 4/physiologyDisease SusceptibilityFemaleGlucagon-Like Peptide 1/adverse effectsGlucagon-Like Peptide 1/agonistsGlucagon-Like Peptide 1/analogs & derivativesHumansHypoglycemic Agents/adverse effectsHypoglycemic Agents/therapeutic useHypoglycemic Agents/toxicityInfections/etiologyLiraglutidePancreatitis/chemically inducedPharmacovigilancePioglitazonePyrazines/adverse effectsRisk AssessmentSafety-Based Drug WithdrawalsSitagliptin PhosphateSpecies SpecificityThiazolidinediones/adverse effectsThiazolidinediones/toxicityThyroid Neoplasms/chemically inducedTriazoles/adverse effectsUrinary Bladder Neoplasms/chemically inducedUrinary Bladder Neoplasms/epidemiology
Substances： See more » Hypoglycemic AgentsPyrazinesThiazolidinedionesTriazolesLiraglutideGlucagon-Like Peptide 1CalcitoninDPP4 protein, humanDipeptidyl Peptidase 4Sitagliptin PhosphatePioglitazone
Year: 2011 PMID： 22177885 DOI： 10.1016/j.endonu.2011.11.002
Source DB: PubMed Journal: Endocrinol Nutr ISSN： 1575-0922